Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Historical Holders from Q2 2015 to Q3 2025

Symbol
VKTX on Nasdaq
CUSIP
92686J106
Type / Class
Equity / COMMON STOCK
Shares outstanding
112M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
76.2M
Holdings value
$2.02B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
386
Number of buys
222
Number of sells
-164
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 8.7% -13% $269M -$40.8M 9.77M -13.2% FMR LLC Jun 30, 2025
BlackRock, Inc. 4.5% -16% $112M -$18.7M 5.03M -14.3% BlackRock, Inc. Mar 31, 2025

Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 454K $11.9M -$9.3M $26.28 29
2025 Q2 76.2M $2.02B +$15.6M $26.50 386
2025 Q1 76.2M $1.84B -$233M $24.15 365
2024 Q4 82M $3.3B -$89.7M $40.24 404
2024 Q3 81.6M $5.17B +$153M $63.31 427
2024 Q2 80.3M $4.26B -$165M $53.01 389
2024 Q1 79.9M $6.55B +$414M $82.00 376
2023 Q4 259K $4.87M -$813K $18.61 4
2023 Q3 76.8M $850M +$8.13M $11.07 175
2023 Q2 74.2M $1.2B +$120M $16.21 190
2023 Q1 66.5M $1.11B +$547M $16.65 182
2022 Q4 34M $320M +$76.4M $9.40 126
2022 Q3 26.4M $71.8M +$426K $2.72 92
2022 Q2 25.6M $73.3M -$13.6M $2.89 91
2022 Q1 30.5M $91.5M -$17.1M $3.00 126
2021 Q4 35.9M $165M -$7.73M $4.60 129
2021 Q3 37.1M $233M +$704K $6.28 125
2021 Q2 37.7M $226M -$18.9M $5.99 131
2021 Q1 40.9M $259M +$21.3M $6.32 138
2020 Q4 37.7M $212M -$11M $5.63 133
2020 Q3 39.5M $230M -$3.96M $5.82 136
2020 Q2 39.9M $288M +$7.62M $7.21 127
2020 Q1 35.6M $167M -$7.94M $4.68 123
2019 Q4 39.3M $315M -$6.19M $8.02 128
2019 Q3 40.5M $279M -$33.6M $6.88 136
2019 Q2 45.1M $374M -$7.41M $8.30 148
2019 Q1 45.7M $454M -$5.08M $9.94 157
2018 Q4 46.8M $358M -$8.64M $7.65 155
2018 Q3 43.2M $750M +$279M $17.42 146
2018 Q2 31.5M $297M +$125M $9.49 114
2018 Q1 20.9M $91.4M +$50.6M $4.37 62
2017 Q4 9.33M $37.9M +$30.1M $4.06 32
2017 Q3 2.02M $3.85M +$1.49M $1.91 16
2017 Q2 1.57M $1.69M +$856K $1.08 9
2017 Q1 770K $1.12M +$227K $1.46 10
2016 Q4 635K $756K -$869K $1.19 10
2016 Q3 1.21M $1.7M +$496K $1.41 12
2016 Q2 859K $1.08M +$1.03M $1.26 11
2016 Q1 44.4K $65K -$26K $1.53 6
2015 Q4 41.3K $140K -$14.6K $3.36 5
2015 Q3 43.2K $252K -$77.6K $5.83 6
2015 Q2 54K $384K +$384K $7.10 5